Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hematological Malignancies
100%
Lymphoma
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
Co-registration
100%
Radiation Treatment Planning
100%
Positron Emission Tomography/computed Tomography (PET/CT)
100%
Gross Tumor Volume
64%
Nuclear Medicine Physician
50%
Radiation Oncologist
42%
Computed Tomography
35%
Patient Median
14%
Prior Chemotherapy
7%
Non-Hodgkin Lymphoma
7%
Assure
7%
Prescription Drugs
7%
Hodgkin Lymphoma
7%
Treatment Plan
7%
Treatment Planning
7%
Paired T-test
7%
Pearson Correlation Coefficient
7%
Test Statistic
7%
Bland-Altman Plot
7%
Interobserver
7%
Relapsed Disease
7%
Single Institution Study
7%
Treatment Dose
7%
Dose-volume Histogram
7%
Plasma Cell Neoplasm
7%
Target Coverage
7%
Volume Emission Rate
7%
Target Volume Definition
7%
Physician Volume
7%
Volume Coverage
7%
Marginal Miss
7%
Positron Emission Tomography Scan
7%
Medicine and Dentistry
Prospective Study
100%
Computer Assisted Tomography
100%
Hematologic Malignancy
100%
Positron Emission Tomography
100%
Radiation Treatment Planning
100%
Neoplasm
81%
Nuclear Medicine Physician
63%
Radiation Oncologist
54%
Positron Emission Tomography-Computed Tomography
36%
Non-Hodgkin Lymphoma
9%
Hodgkin's Lymphoma
9%
Treatment Planning
9%
Student T Test
9%
Plasmacytoma
9%
Fluorodeoxyglucose
9%
Computed Tomography Studies
9%
Patient History of Chemotherapy
9%
Fluorine-18
9%
Bland-Altman Plot
9%
Dose-Volume Histogram
9%
Diseases
9%
Volume Coverage
9%